George Clinical

Our SGLT2 Trialists Consortium (SMART-C) analysis on the added cardiovascular and kidney benefits of combining SGLT2 inhibitors and GLP-1 receptor agonists, such as Ozempic, was featured in yesterday's Australian newspapers The Sydney Morning Herald and The Age (with a few additional comments from me and the University of Sydney's Professor Stephen Twigg) The George Institute for Global Health George Clinical Northern Sydney Local Health District Royal North Shore Hospital NORTH Foundation Kidney Health Australia https://lnkd.in/eEGNXzgT

It's not too late! Jake L. and his George Clinical team look forward to meeting you at BIO Asia–Taiwan and discussing potential collaborations, industry insights, and innovative solutions. Talk soon! #ScienceServiceSolutions #ImprovingHealthWorldwide #NooneLeftBehind #ClinicalTrials #Taiwan

George Clinical is pleased to confirm the appointment of Mary Gunn, PhD, MBA, MA, LLM as its new Chief Executive Officer. As a global executive, Mary brings to the role extensive experience in high-growth life sciences, financial services, and the education sectors. Mary will also be a director on the Board. Mary Gunn succeeds James Cheong who has served as CEO for five and a half years. The Board of George Clinical extends its gratitude to James for his dedication and significant contributions to the company over this time. #ScienceServiceSolutions #ImprovingHealthWorldwide #NooneLeftBehind #ClinicalTrials #Leadership

THIS WEEK! George Clinical will be attending BIO Asia–Taiwan this year as part of the Australian Trade and Investment Commission (Austrade) Taiwan Pavilion. We'd love to discuss industry trends, innovative solutions, and potential collaboration on your upcoming studies. Set up a time to meet with Jake L.. #ScienceServiceSolutions #ImprovingHealthWorldwide #NooneLeftBehind #ClinicalTrials

AI Era - Insights into US, China, and Europe’s regulations and clinical strategies Time: Wednesday, July 24, 2024, 19:00-20:30 On July 24, 2024 (Wednesday) from 19:00 to 20:30, bioSeedin will co-host the 189th Webinar with EC Innovations - "The AI Era - China, the United States and Europe Regulatory Insights and Clinical Strategies" , and George Clinical is invited to participate. This live broadcast invited George Clinical Regulatory Affairs Consultant Jin Shun , Chuangshi Lixin Group Vice President Wei Sijie , and George Clinical Project Management Director Alice Lin to give us live speeches on the topics of "IND Process and Strategy in China, the United States and Europe" , "In the AI era, how can large language models enable biopharmaceutical companies to improve new quality productivity?" and "Key Considerations for Clinical Trials in China, the United States and Europe" Scan the QR code to register and watch. #ScienceServiceSolutions #ImprovingHealthWorldwide #NooneLeftBehind #ClinicalTrials #China

#ScientificLeadership #IgAN #CJASN Jonathan Barratt Haresh Selvaskandan

We will be there. Will you? It is only one week away. Meet with Jake L. and our George Clinical team at the Australian Trade and Investment Commission (Austrade) Pavillion at BIO Asia–Taiwan. See you there! #ScienceServiceSolutions #ImprovingHealthWorldwide #NooneLeftBehind #ClinicalTrials #BIOAsiaTaiwan2024

#ScientificLeadership Brendon L Neuen

In recognition of GIST Awareness Day, a rare soft tissue sarcoma, we would like to show our support to all those who have had to deal with GIST firsthand as well as recognize the great efforts of oncologists globally that diligently treat GIST patients and help drive research to find new treatments for GIST. At George Clinical, we have global expertise in GIST, rare cancers, and GI tumors along with a network of Scientific Leaders to drive the successful completion of trials for GIST and other rare and GI cancers. #ScienceServiceSolutions #ImprovingHealthWorldwide #NooneLeftBehind #ClinicalTrials #GIST

Why conduct your study in Taiwan? Shanny Chen explains why. Learn more from the George Clinical team at BIO Asia–Taiwan. Reach out to Jake L. to set up a time to talk. #ScienceServiceSolutions #ImprovingHealthWorldwide #NooneLeftBehind #ClinicalTrials #Taiwan